Paradromics | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

Paradromics is a biotechnology research company focused on developing advanced brain-computer interface (BCI) technologies aimed...


Paradromics LinkedIn profile Paradromics X profile Paradromics Crunchbase profile Paradromics Facebook profile
Paradromics logo

Paradromics is a biotechnology research company focused on developing advanced brain-computer interface (BCI) technologies aimed at improving brain health. Founded in 2015, the company specializes in high-resolution neural interfaces that decode brain activity to provide solutions for various medical conditions, including paralysis, chronic pain, and mental health disorders. Their flagship product, Connexus, is designed for long-term medical use and aims to help individuals with unmet medical needs.

Website
Headquarters
Austin, Texas
Size
51-200 employees
Industry
Biotechnology Research
Specialities
Neural Interfaces, Brain Computer Interface, Assistive Communication Devices, BCI, Neuroscience, Neurotechnology

🛍️ Paradromics Product and Pricing News →

👔 Paradromics CEO, Management and Leadership Team →

⚔️ Paradromics Alternatives and Competitors →

💼 Paradromics Hiring and Layoffs →

🤖 Paradromics Developer, Integration and Automation News →

📈 Paradromics Financials, Fundraising and Valuation News →

Monitor your competitors, key accounts, or your own company with RivalSense AI

🛍️ Paradromics Product and Pricing News

  • On May 14, 2025, Prof Andreas Schaefer, Co-Founder of Paradromics, will participate in a panel discussion at Jesus College, Oxford, about the science and ethics of brain-computer interfaces.
  • Paradromics CEO Matt Angle hosts an informal salon with influential figures in neurotechnology.
  • Matt Angle, CEO of Paradromics, discussed using brain implants to restore senses for the blind or deaf by directly inputting data from cameras or microphones.


👔 Paradromics CEO, Management and Leadership Team


⚔️ Paradromics Alternatives and Competitors

  • Blackrock Neurotech
  • |
  • Kernel
  • |
  • Neuralink
  • |
  • Synchron
  • |
  • BrainCo_Tech
  • |
  • BrainGate
  • |
  • Supira Medical
  • |
  • P3 Health Partners
  • |
  • Turn Medical

Monitor your competitors, key accounts, or your own company with RivalSense AI


💼 Paradromics Hiring and Layoffs

  • Stephen Ryu has joined Paradromics as Chief Medical Officer in the United States, previously serving in the same role at another company.
  • Paradromics announced Stephen Ryu, MD, as Chief Medical Officer.


🤖 Paradromics Developer, Integration and Automation News


📈 Paradromics Financials, Fundraising and Valuation News

  • Leo Lion Limited has invested in Paradromics to support their development of high-bandwidth brain-computer interfaces aimed at restoring communication for people with severe neurological conditions.


People also viewed